nodes	percent_of_prediction	percent_of_DWPC	metapath
Methamphetamine—SLC18A1—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.00801	0.00826	CbGpPWpGaD
Methamphetamine—SLC18A1—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.00801	0.00826	CbGpPWpGaD
Methamphetamine—ADRA2B—Amine ligand-binding receptors—CHRM3—nephrolithiasis	0.00723	0.00745	CbGpPWpGaD
Methamphetamine—SLC6A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A12—nephrolithiasis	0.00722	0.00744	CbGpPWpGaD
Methamphetamine—SLC18A2—SLC-mediated transmembrane transport—SLC26A6—nephrolithiasis	0.00703	0.00725	CbGpPWpGaD
Methamphetamine—ADRA2C—Amine ligand-binding receptors—CHRM3—nephrolithiasis	0.00675	0.00696	CbGpPWpGaD
Methamphetamine—SLC6A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A9—nephrolithiasis	0.00671	0.00692	CbGpPWpGaD
Methamphetamine—ADRA2A—Monoamine GPCRs—CHRM3—nephrolithiasis	0.00652	0.00673	CbGpPWpGaD
Methamphetamine—MAOB—Biological oxidations—SLC26A1—nephrolithiasis	0.00645	0.00665	CbGpPWpGaD
Methamphetamine—SLC18A2—SLC-mediated transmembrane transport—SLC34A3—nephrolithiasis	0.00643	0.00663	CbGpPWpGaD
Methamphetamine—SLC18A2—SLC-mediated transmembrane transport—SLC3A1—nephrolithiasis	0.00643	0.00663	CbGpPWpGaD
Methamphetamine—SLC6A3—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A12—nephrolithiasis	0.0064	0.00659	CbGpPWpGaD
Methamphetamine—SLC22A3—SLC-mediated transmembrane transport—SLC26A6—nephrolithiasis	0.00608	0.00627	CbGpPWpGaD
Methamphetamine—SLC18A1—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.00607	0.00626	CbGpPWpGaD
Methamphetamine—SLC18A1—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.00607	0.00626	CbGpPWpGaD
Methamphetamine—SLC22A5—SLC-mediated transmembrane transport—SLC26A6—nephrolithiasis	0.00606	0.00625	CbGpPWpGaD
Methamphetamine—SLC6A3—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A9—nephrolithiasis	0.00595	0.00613	CbGpPWpGaD
Methamphetamine—SLC18A1—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.00564	0.00582	CbGpPWpGaD
Methamphetamine—SLC18A1—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.00564	0.00582	CbGpPWpGaD
Methamphetamine—SLC6A4—NRF2 pathway—SLC2A9—nephrolithiasis	0.00563	0.0058	CbGpPWpGaD
Methamphetamine—SLC22A3—SLC-mediated transmembrane transport—SLC34A3—nephrolithiasis	0.00556	0.00574	CbGpPWpGaD
Methamphetamine—SLC22A3—SLC-mediated transmembrane transport—SLC3A1—nephrolithiasis	0.00556	0.00574	CbGpPWpGaD
Methamphetamine—SLC22A5—SLC-mediated transmembrane transport—SLC34A3—nephrolithiasis	0.00554	0.00572	CbGpPWpGaD
Methamphetamine—SLC22A5—SLC-mediated transmembrane transport—SLC3A1—nephrolithiasis	0.00554	0.00572	CbGpPWpGaD
Methamphetamine—ADRA2A—Amine ligand-binding receptors—CHRM3—nephrolithiasis	0.00548	0.00566	CbGpPWpGaD
Methamphetamine—TAAR1—Class A/1 (Rhodopsin-like receptors)—CHRM3—nephrolithiasis	0.00517	0.00533	CbGpPWpGaD
Methamphetamine—SLC18A1—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.00503	0.00518	CbGpPWpGaD
Methamphetamine—SLC18A1—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.00503	0.00518	CbGpPWpGaD
Methamphetamine—SLC18A2—SLC-mediated transmembrane transport—SLC34A1—nephrolithiasis	0.00487	0.00503	CbGpPWpGaD
Methamphetamine—SLC18A2—SLC-mediated transmembrane transport—SLC22A12—nephrolithiasis	0.00487	0.00503	CbGpPWpGaD
Methamphetamine—SLC6A2—NRF2 pathway—SLC2A9—nephrolithiasis	0.00484	0.00499	CbGpPWpGaD
Methamphetamine—SLC6A2—SLC-mediated transmembrane transport—SLC26A6—nephrolithiasis	0.00473	0.00488	CbGpPWpGaD
Methamphetamine—TAAR1—GPCR downstream signaling—RGS14—nephrolithiasis	0.00455	0.0047	CbGpPWpGaD
Methamphetamine—SLC18A2—SLC-mediated transmembrane transport—SLC26A1—nephrolithiasis	0.00453	0.00467	CbGpPWpGaD
Methamphetamine—SLC18A2—SLC-mediated transmembrane transport—SLC2A9—nephrolithiasis	0.00453	0.00467	CbGpPWpGaD
Methamphetamine—SLC6A2—SLC-mediated transmembrane transport—SLC3A1—nephrolithiasis	0.00433	0.00446	CbGpPWpGaD
Methamphetamine—SLC6A2—SLC-mediated transmembrane transport—SLC34A3—nephrolithiasis	0.00433	0.00446	CbGpPWpGaD
Methamphetamine—SLC6A3—NRF2 pathway—SLC2A9—nephrolithiasis	0.00429	0.00442	CbGpPWpGaD
Methamphetamine—SLC22A3—SLC-mediated transmembrane transport—SLC22A12—nephrolithiasis	0.00422	0.00435	CbGpPWpGaD
Methamphetamine—SLC22A3—SLC-mediated transmembrane transport—SLC34A1—nephrolithiasis	0.00422	0.00435	CbGpPWpGaD
Methamphetamine—SLC22A5—SLC-mediated transmembrane transport—SLC34A1—nephrolithiasis	0.0042	0.00433	CbGpPWpGaD
Methamphetamine—SLC22A5—SLC-mediated transmembrane transport—SLC22A12—nephrolithiasis	0.0042	0.00433	CbGpPWpGaD
Methamphetamine—SLC6A3—SLC-mediated transmembrane transport—SLC26A6—nephrolithiasis	0.00419	0.00432	CbGpPWpGaD
Methamphetamine—TAAR1—Signaling by GPCR—RGS14—nephrolithiasis	0.00414	0.00426	CbGpPWpGaD
Methamphetamine—ADRA2C—Regulation of insulin secretion—CHRM3—nephrolithiasis	0.00408	0.00421	CbGpPWpGaD
Methamphetamine—MAOA—Biological oxidations—SLC26A1—nephrolithiasis	0.00405	0.00417	CbGpPWpGaD
Methamphetamine—SLC18A2—SLC-mediated transmembrane transport—SLC7A9—nephrolithiasis	0.00404	0.00417	CbGpPWpGaD
Methamphetamine—SLC18A1—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.00402	0.00414	CbGpPWpGaD
Methamphetamine—SLC18A2—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.00401	0.00413	CbGpPWpGaD
Methamphetamine—SLC18A2—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.00401	0.00413	CbGpPWpGaD
Methamphetamine—TAAR1—GPCR ligand binding—CHRM3—nephrolithiasis	0.00394	0.00406	CbGpPWpGaD
Methamphetamine—SLC22A3—SLC-mediated transmembrane transport—SLC2A9—nephrolithiasis	0.00392	0.00404	CbGpPWpGaD
Methamphetamine—SLC22A3—SLC-mediated transmembrane transport—SLC26A1—nephrolithiasis	0.00392	0.00404	CbGpPWpGaD
Methamphetamine—SLC22A5—SLC-mediated transmembrane transport—SLC26A1—nephrolithiasis	0.00391	0.00403	CbGpPWpGaD
Methamphetamine—SLC22A5—SLC-mediated transmembrane transport—SLC2A9—nephrolithiasis	0.00391	0.00403	CbGpPWpGaD
Methamphetamine—SLC6A3—SLC-mediated transmembrane transport—SLC34A3—nephrolithiasis	0.00383	0.00395	CbGpPWpGaD
Methamphetamine—SLC6A3—SLC-mediated transmembrane transport—SLC3A1—nephrolithiasis	0.00383	0.00395	CbGpPWpGaD
Methamphetamine—ADRA2B—G alpha (i) signalling events—RGS14—nephrolithiasis	0.00366	0.00378	CbGpPWpGaD
Methamphetamine—TAAR1—GPCR ligand binding—PTH—nephrolithiasis	0.0036	0.00371	CbGpPWpGaD
Methamphetamine—SLC18A2—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.00357	0.00369	CbGpPWpGaD
Methamphetamine—SLC22A3—SLC-mediated transmembrane transport—SLC7A9—nephrolithiasis	0.00349	0.0036	CbGpPWpGaD
Methamphetamine—SLC22A5—SLC-mediated transmembrane transport—SLC7A9—nephrolithiasis	0.00348	0.00359	CbGpPWpGaD
Methamphetamine—SLC22A3—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.00347	0.00358	CbGpPWpGaD
Methamphetamine—SLC22A3—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.00347	0.00358	CbGpPWpGaD
Methamphetamine—SLC22A5—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.00346	0.00356	CbGpPWpGaD
Methamphetamine—SLC22A5—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.00346	0.00356	CbGpPWpGaD
Methamphetamine—ADRA2C—G alpha (i) signalling events—RGS14—nephrolithiasis	0.00342	0.00353	CbGpPWpGaD
Methamphetamine—ADRA2A—Regulation of insulin secretion—CHRM3—nephrolithiasis	0.00331	0.00342	CbGpPWpGaD
Methamphetamine—SLC6A2—SLC-mediated transmembrane transport—SLC34A1—nephrolithiasis	0.00328	0.00338	CbGpPWpGaD
Methamphetamine—SLC6A2—SLC-mediated transmembrane transport—SLC22A12—nephrolithiasis	0.00328	0.00338	CbGpPWpGaD
Methamphetamine—SLC18A2—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.00327	0.00337	CbGpPWpGaD
Methamphetamine—SLC18A2—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.00327	0.00337	CbGpPWpGaD
Methamphetamine—ADRA2C—Integration of energy metabolism—CHRM3—nephrolithiasis	0.00321	0.00331	CbGpPWpGaD
Methamphetamine—CYP2D6—urine—nephrolithiasis	0.00318	0.105	CbGeAlD
Methamphetamine—SLC22A3—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.00309	0.00319	CbGpPWpGaD
Methamphetamine—SLC22A5—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.00308	0.00318	CbGpPWpGaD
Methamphetamine—TAAR1—GPCR downstream signaling—DGKH—nephrolithiasis	0.00308	0.00317	CbGpPWpGaD
Methamphetamine—SLC6A2—SLC-mediated transmembrane transport—SLC26A1—nephrolithiasis	0.00305	0.00314	CbGpPWpGaD
Methamphetamine—SLC6A2—SLC-mediated transmembrane transport—SLC2A9—nephrolithiasis	0.00305	0.00314	CbGpPWpGaD
Methamphetamine—SLC6A3—SLC-mediated transmembrane transport—SLC34A1—nephrolithiasis	0.00291	0.003	CbGpPWpGaD
Methamphetamine—SLC6A3—SLC-mediated transmembrane transport—SLC22A12—nephrolithiasis	0.00291	0.003	CbGpPWpGaD
Methamphetamine—TAAR1—Signaling Pathways—ADCY10—nephrolithiasis	0.00287	0.00296	CbGpPWpGaD
Methamphetamine—SLC22A3—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.00283	0.00291	CbGpPWpGaD
Methamphetamine—SLC22A3—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.00283	0.00291	CbGpPWpGaD
Methamphetamine—SLC22A5—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.00282	0.00291	CbGpPWpGaD
Methamphetamine—SLC22A5—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.00282	0.00291	CbGpPWpGaD
Methamphetamine—TAAR1—Signaling by GPCR—DGKH—nephrolithiasis	0.00279	0.00288	CbGpPWpGaD
Methamphetamine—ADRA2A—G alpha (i) signalling events—RGS14—nephrolithiasis	0.00278	0.00286	CbGpPWpGaD
Methamphetamine—SLC6A2—SLC-mediated transmembrane transport—SLC7A9—nephrolithiasis	0.00272	0.0028	CbGpPWpGaD
Methamphetamine—SLC6A3—SLC-mediated transmembrane transport—SLC26A1—nephrolithiasis	0.0027	0.00279	CbGpPWpGaD
Methamphetamine—SLC6A3—SLC-mediated transmembrane transport—SLC2A9—nephrolithiasis	0.0027	0.00279	CbGpPWpGaD
Methamphetamine—SLC6A2—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.0027	0.00278	CbGpPWpGaD
Methamphetamine—SLC6A2—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.0027	0.00278	CbGpPWpGaD
Methamphetamine—ADRA2A—Integration of energy metabolism—CHRM3—nephrolithiasis	0.0026	0.00269	CbGpPWpGaD
Methamphetamine—ADRA2B—Platelet activation, signaling and aggregation—DGKH—nephrolithiasis	0.0026	0.00268	CbGpPWpGaD
Methamphetamine—SLC18A2—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.00248	0.00255	CbGpPWpGaD
Methamphetamine—SLC18A2—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.00248	0.00255	CbGpPWpGaD
Methamphetamine—TAAR1—Signaling Pathways—RGS14—nephrolithiasis	0.00244	0.00252	CbGpPWpGaD
Methamphetamine—ADRA2C—Platelet activation, signaling and aggregation—DGKH—nephrolithiasis	0.00243	0.0025	CbGpPWpGaD
Methamphetamine—SLC6A3—SLC-mediated transmembrane transport—SLC7A9—nephrolithiasis	0.00241	0.00248	CbGpPWpGaD
Methamphetamine—SLC6A2—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.0024	0.00248	CbGpPWpGaD
Methamphetamine—SLC6A3—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.00239	0.00246	CbGpPWpGaD
Methamphetamine—SLC6A3—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.00239	0.00246	CbGpPWpGaD
Methamphetamine—SLC18A2—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.0023	0.00237	CbGpPWpGaD
Methamphetamine—SLC18A2—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.0023	0.00237	CbGpPWpGaD
Methamphetamine—TAAR1—GPCR downstream signaling—CHRM3—nephrolithiasis	0.00222	0.00229	CbGpPWpGaD
Methamphetamine—SLC6A2—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.0022	0.00227	CbGpPWpGaD
Methamphetamine—SLC6A2—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.0022	0.00227	CbGpPWpGaD
Methamphetamine—SLC22A3—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.00214	0.00221	CbGpPWpGaD
Methamphetamine—SLC22A3—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.00214	0.00221	CbGpPWpGaD
Methamphetamine—SLC22A5—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.00214	0.0022	CbGpPWpGaD
Methamphetamine—SLC22A5—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.00214	0.0022	CbGpPWpGaD
Methamphetamine—SLC6A3—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.00213	0.0022	CbGpPWpGaD
Methamphetamine—SLC18A2—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.00205	0.00212	CbGpPWpGaD
Methamphetamine—SLC18A2—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.00205	0.00212	CbGpPWpGaD
Methamphetamine—TAAR1—GPCR downstream signaling—PTH—nephrolithiasis	0.00203	0.0021	CbGpPWpGaD
Methamphetamine—TAAR1—Signaling by GPCR—CHRM3—nephrolithiasis	0.00202	0.00208	CbGpPWpGaD
Methamphetamine—SLC22A3—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.00199	0.00205	CbGpPWpGaD
Methamphetamine—SLC22A3—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.00199	0.00205	CbGpPWpGaD
Methamphetamine—SLC22A5—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.00199	0.00205	CbGpPWpGaD
Methamphetamine—SLC22A5—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.00199	0.00205	CbGpPWpGaD
Methamphetamine—ADRA2A—Platelet activation, signaling and aggregation—DGKH—nephrolithiasis	0.00197	0.00203	CbGpPWpGaD
Methamphetamine—SLC6A3—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.00195	0.00201	CbGpPWpGaD
Methamphetamine—SLC6A3—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.00195	0.00201	CbGpPWpGaD
Methamphetamine—TAAR1—Signaling by GPCR—PTH—nephrolithiasis	0.00185	0.0019	CbGpPWpGaD
Methamphetamine—SLC22A3—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.00178	0.00183	CbGpPWpGaD
Methamphetamine—SLC22A3—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.00178	0.00183	CbGpPWpGaD
Methamphetamine—SLC22A5—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.00177	0.00182	CbGpPWpGaD
Methamphetamine—SLC22A5—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.00177	0.00182	CbGpPWpGaD
Methamphetamine—CYP2D6—Biological oxidations—SLC26A1—nephrolithiasis	0.00176	0.00182	CbGpPWpGaD
Methamphetamine—MAOB—nephron tubule—nephrolithiasis	0.00169	0.0559	CbGeAlD
Methamphetamine—SLC6A2—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.00167	0.00172	CbGpPWpGaD
Methamphetamine—SLC6A2—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.00167	0.00172	CbGpPWpGaD
Methamphetamine—ADRA2B—GPCRs, Class A Rhodopsin-like—CHRM3—nephrolithiasis	0.00166	0.00171	CbGpPWpGaD
Methamphetamine—SLC22A3—renal system—nephrolithiasis	0.00166	0.0549	CbGeAlD
Methamphetamine—TAAR1—Signaling Pathways—DGKH—nephrolithiasis	0.00165	0.0017	CbGpPWpGaD
Methamphetamine—TAAR1—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.00165	0.0017	CbGpPWpGaD
Methamphetamine—SLC18A2—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.00164	0.00169	CbGpPWpGaD
Methamphetamine—SLC22A3—kidney—nephrolithiasis	0.0016	0.0531	CbGeAlD
Methamphetamine—ADRA2C—GPCRs, Class A Rhodopsin-like—CHRM3—nephrolithiasis	0.00155	0.0016	CbGpPWpGaD
Methamphetamine—SLC6A2—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.00155	0.0016	CbGpPWpGaD
Methamphetamine—SLC6A2—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.00155	0.0016	CbGpPWpGaD
Methamphetamine—MAOB—renal system—nephrolithiasis	0.00153	0.0508	CbGeAlD
Methamphetamine—MAOB—kidney—nephrolithiasis	0.00148	0.0491	CbGeAlD
Methamphetamine—SLC6A3—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.00148	0.00152	CbGpPWpGaD
Methamphetamine—SLC6A3—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.00148	0.00152	CbGpPWpGaD
Methamphetamine—MAOB—Metabolism—GRHPR—nephrolithiasis	0.00145	0.0015	CbGpPWpGaD
Methamphetamine—MAOB—cortex of kidney—nephrolithiasis	0.00144	0.0478	CbGeAlD
Methamphetamine—MAOA—nephron tubule—nephrolithiasis	0.00144	0.0477	CbGeAlD
Methamphetamine—ADRA2B—Class A/1 (Rhodopsin-like receptors)—CHRM3—nephrolithiasis	0.00142	0.00147	CbGpPWpGaD
Methamphetamine—SLC22A3—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.00142	0.00146	CbGpPWpGaD
Methamphetamine—SLC22A5—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.00141	0.00146	CbGpPWpGaD
Methamphetamine—ADRA2C—nephron tubule—nephrolithiasis	0.00138	0.0459	CbGeAlD
Methamphetamine—SLC6A2—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.00138	0.00142	CbGpPWpGaD
Methamphetamine—SLC6A2—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.00138	0.00142	CbGpPWpGaD
Methamphetamine—SLC6A3—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.00137	0.00142	CbGpPWpGaD
Methamphetamine—SLC6A3—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.00137	0.00142	CbGpPWpGaD
Methamphetamine—ADRA2B—Hemostasis—SLC7A9—nephrolithiasis	0.00134	0.00138	CbGpPWpGaD
Methamphetamine—ADRA2B—Hemostasis—DGKH—nephrolithiasis	0.00134	0.00138	CbGpPWpGaD
Methamphetamine—ADRA2C—Class A/1 (Rhodopsin-like receptors)—CHRM3—nephrolithiasis	0.00133	0.00137	CbGpPWpGaD
Methamphetamine—SLC22A5—nephron tubule—nephrolithiasis	0.00133	0.0439	CbGeAlD
Methamphetamine—MAOA—renal system—nephrolithiasis	0.00131	0.0434	CbGeAlD
Methamphetamine—MAOB—Metabolism—AGXT—nephrolithiasis	0.0013	0.00134	CbGpPWpGaD
Methamphetamine—MAOA—kidney—nephrolithiasis	0.00126	0.0419	CbGeAlD
Methamphetamine—ADRA2A—GPCRs, Class A Rhodopsin-like—CHRM3—nephrolithiasis	0.00126	0.0013	CbGpPWpGaD
Methamphetamine—ADRA2C—renal system—nephrolithiasis	0.00126	0.0417	CbGeAlD
Methamphetamine—ADRA2B—GPCR downstream signaling—RGS14—nephrolithiasis	0.00125	0.00129	CbGpPWpGaD
Methamphetamine—ADRA2C—Hemostasis—DGKH—nephrolithiasis	0.00125	0.00129	CbGpPWpGaD
Methamphetamine—ADRA2C—Hemostasis—SLC7A9—nephrolithiasis	0.00125	0.00129	CbGpPWpGaD
Methamphetamine—MAOA—cortex of kidney—nephrolithiasis	0.00123	0.0408	CbGeAlD
Methamphetamine—SLC22A3—Metabolism—GRHPR—nephrolithiasis	0.00123	0.00127	CbGpPWpGaD
Methamphetamine—SLC6A3—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.00122	0.00126	CbGpPWpGaD
Methamphetamine—SLC6A3—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.00122	0.00126	CbGpPWpGaD
Methamphetamine—ADRA2C—kidney—nephrolithiasis	0.00122	0.0403	CbGeAlD
Methamphetamine—SLC22A5—renal system—nephrolithiasis	0.0012	0.0399	CbGeAlD
Methamphetamine—TAAR1—Signaling Pathways—CHRM3—nephrolithiasis	0.00119	0.00123	CbGpPWpGaD
Methamphetamine—ADRA2C—cortex of kidney—nephrolithiasis	0.00118	0.0393	CbGeAlD
Methamphetamine—ADRA2C—GPCR downstream signaling—RGS14—nephrolithiasis	0.00117	0.00121	CbGpPWpGaD
Methamphetamine—SLC22A5—kidney—nephrolithiasis	0.00116	0.0386	CbGeAlD
Methamphetamine—ADRA2B—Signaling by GPCR—RGS14—nephrolithiasis	0.00114	0.00117	CbGpPWpGaD
Methamphetamine—SLC22A5—cortex of kidney—nephrolithiasis	0.00113	0.0376	CbGeAlD
Methamphetamine—SLC6A2—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.0011	0.00114	CbGpPWpGaD
Methamphetamine—MAOB—Metabolism—SLC26A1—nephrolithiasis	0.0011	0.00114	CbGpPWpGaD
Methamphetamine—MAOB—Metabolism—APRT—nephrolithiasis	0.0011	0.00114	CbGpPWpGaD
Methamphetamine—SLC22A3—Metabolism—AGXT—nephrolithiasis	0.0011	0.00113	CbGpPWpGaD
Methamphetamine—TAAR1—Signaling Pathways—PTH—nephrolithiasis	0.00109	0.00113	CbGpPWpGaD
Methamphetamine—ADRA2B—GPCR ligand binding—CHRM3—nephrolithiasis	0.00108	0.00112	CbGpPWpGaD
Methamphetamine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—CHRM3—nephrolithiasis	0.00108	0.00111	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling by GPCR—RGS14—nephrolithiasis	0.00106	0.0011	CbGpPWpGaD
Methamphetamine—ADRA2A—Hemostasis—SLC7A9—nephrolithiasis	0.00102	0.00105	CbGpPWpGaD
Methamphetamine—ADRA2A—Hemostasis—DGKH—nephrolithiasis	0.00102	0.00105	CbGpPWpGaD
Methamphetamine—ADRA2C—GPCR ligand binding—CHRM3—nephrolithiasis	0.00101	0.00104	CbGpPWpGaD
Methamphetamine—ADRA2B—GPCR ligand binding—PTH—nephrolithiasis	0.00099	0.00102	CbGpPWpGaD
Methamphetamine—SLC6A3—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.000978	0.00101	CbGpPWpGaD
Methamphetamine—ADRA2A—GPCR downstream signaling—RGS14—nephrolithiasis	0.000951	0.00098	CbGpPWpGaD
Methamphetamine—ADRA2A—cortex of kidney—nephrolithiasis	0.000945	0.0313	CbGeAlD
Methamphetamine—SLC22A3—Metabolism—APRT—nephrolithiasis	0.000933	0.000962	CbGpPWpGaD
Methamphetamine—SLC22A3—Metabolism—SLC26A1—nephrolithiasis	0.000933	0.000962	CbGpPWpGaD
Methamphetamine—ADRA2C—GPCR ligand binding—PTH—nephrolithiasis	0.000925	0.000954	CbGpPWpGaD
Methamphetamine—MAOA—Metabolism—GRHPR—nephrolithiasis	0.000913	0.000941	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling by GPCR—RGS14—nephrolithiasis	0.000863	0.00089	CbGpPWpGaD
Methamphetamine—ADRA2B—GPCR downstream signaling—DGKH—nephrolithiasis	0.000846	0.000873	CbGpPWpGaD
Methamphetamine—ADRA2A—GPCR ligand binding—CHRM3—nephrolithiasis	0.000822	0.000847	CbGpPWpGaD
Methamphetamine—MAOA—Metabolism—AGXT—nephrolithiasis	0.000814	0.000839	CbGpPWpGaD
Methamphetamine—ADRA2C—GPCR downstream signaling—DGKH—nephrolithiasis	0.000791	0.000815	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—ADCY10—nephrolithiasis	0.000791	0.000815	CbGpPWpGaD
Methamphetamine—MAOB—Metabolism—AQP1—nephrolithiasis	0.000786	0.00081	CbGpPWpGaD
Methamphetamine—CYP2D6—renal system—nephrolithiasis	0.000777	0.0258	CbGeAlD
Methamphetamine—ADRA2B—Signaling by GPCR—DGKH—nephrolithiasis	0.000769	0.000792	CbGpPWpGaD
Methamphetamine—CYP2D6—kidney—nephrolithiasis	0.000751	0.0249	CbGeAlD
Methamphetamine—ADRA2A—GPCR ligand binding—PTH—nephrolithiasis	0.000751	0.000775	CbGpPWpGaD
Methamphetamine—ADRA2C—Metabolism—GRHPR—nephrolithiasis	0.000751	0.000774	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—ADCY10—nephrolithiasis	0.000738	0.000761	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling by GPCR—DGKH—nephrolithiasis	0.000718	0.00074	CbGpPWpGaD
Methamphetamine—MAOB—Metabolism—CHRM3—nephrolithiasis	0.00071	0.000733	CbGpPWpGaD
Methamphetamine—MAOA—Metabolism—SLC26A1—nephrolithiasis	0.000692	0.000713	CbGpPWpGaD
Methamphetamine—MAOA—Metabolism—APRT—nephrolithiasis	0.000692	0.000713	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—RGS14—nephrolithiasis	0.000672	0.000693	CbGpPWpGaD
Methamphetamine—ADRA2C—Metabolism—AGXT—nephrolithiasis	0.000669	0.00069	CbGpPWpGaD
Methamphetamine—SLC22A3—Metabolism—AQP1—nephrolithiasis	0.000665	0.000685	CbGpPWpGaD
Methamphetamine—ADRA2A—GPCR downstream signaling—DGKH—nephrolithiasis	0.000642	0.000662	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—RGS14—nephrolithiasis	0.000628	0.000647	CbGpPWpGaD
Methamphetamine—ADRA2B—GPCR downstream signaling—CHRM3—nephrolithiasis	0.000612	0.000631	CbGpPWpGaD
Methamphetamine—ADRA2A—Metabolism—GRHPR—nephrolithiasis	0.00061	0.000629	CbGpPWpGaD
Methamphetamine—SLC22A3—Metabolism—CHRM3—nephrolithiasis	0.000601	0.00062	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—ADCY10—nephrolithiasis	0.0006	0.000618	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling by GPCR—DGKH—nephrolithiasis	0.000583	0.000601	CbGpPWpGaD
Methamphetamine—ADRA2C—GPCR downstream signaling—CHRM3—nephrolithiasis	0.000572	0.000589	CbGpPWpGaD
Methamphetamine—ADRA2C—Metabolism—SLC26A1—nephrolithiasis	0.000569	0.000587	CbGpPWpGaD
Methamphetamine—ADRA2C—Metabolism—APRT—nephrolithiasis	0.000569	0.000587	CbGpPWpGaD
Methamphetamine—ADRA2B—GPCR downstream signaling—PTH—nephrolithiasis	0.00056	0.000577	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling by GPCR—CHRM3—nephrolithiasis	0.000556	0.000573	CbGpPWpGaD
Methamphetamine—TAAR1—Signaling Pathways—SPP1—nephrolithiasis	0.000548	0.000565	CbGpPWpGaD
Methamphetamine—ADRA2A—Metabolism—AGXT—nephrolithiasis	0.000544	0.000561	CbGpPWpGaD
Methamphetamine—ADRA2C—GPCR downstream signaling—PTH—nephrolithiasis	0.000523	0.000539	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling by GPCR—CHRM3—nephrolithiasis	0.000519	0.000535	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—RGS14—nephrolithiasis	0.00051	0.000526	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling by GPCR—PTH—nephrolithiasis	0.000508	0.000524	CbGpPWpGaD
Methamphetamine—MAOA—Metabolism—AQP1—nephrolithiasis	0.000493	0.000508	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling by GPCR—PTH—nephrolithiasis	0.000475	0.000489	CbGpPWpGaD
Methamphetamine—ADRA2A—GPCR downstream signaling—CHRM3—nephrolithiasis	0.000464	0.000479	CbGpPWpGaD
Methamphetamine—ADRA2A—Metabolism—SLC26A1—nephrolithiasis	0.000462	0.000477	CbGpPWpGaD
Methamphetamine—ADRA2A—Metabolism—APRT—nephrolithiasis	0.000462	0.000477	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.000454	0.000468	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—DGKH—nephrolithiasis	0.000454	0.000468	CbGpPWpGaD
Methamphetamine—MAOA—Metabolism—CHRM3—nephrolithiasis	0.000446	0.00046	CbGpPWpGaD
Methamphetamine—ADRA2A—GPCR downstream signaling—PTH—nephrolithiasis	0.000425	0.000438	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—DGKH—nephrolithiasis	0.000424	0.000437	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.000424	0.000437	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling by GPCR—CHRM3—nephrolithiasis	0.000422	0.000435	CbGpPWpGaD
Methamphetamine—ADRA2C—Metabolism—AQP1—nephrolithiasis	0.000405	0.000418	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—GRHPR—nephrolithiasis	0.000397	0.00041	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling by GPCR—PTH—nephrolithiasis	0.000386	0.000398	CbGpPWpGaD
Methamphetamine—ADRA2C—Metabolism—CHRM3—nephrolithiasis	0.000367	0.000378	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—AGXT—nephrolithiasis	0.000354	0.000365	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—DGKH—nephrolithiasis	0.000344	0.000355	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.000344	0.000355	CbGpPWpGaD
Methamphetamine—ADRA2A—Metabolism—AQP1—nephrolithiasis	0.000329	0.00034	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—CHRM3—nephrolithiasis	0.000328	0.000338	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—CHRM3—nephrolithiasis	0.000307	0.000316	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—APRT—nephrolithiasis	0.000301	0.000311	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—SLC26A1—nephrolithiasis	0.000301	0.000311	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—PTH—nephrolithiasis	0.0003	0.00031	CbGpPWpGaD
Methamphetamine—ADRA2A—Metabolism—CHRM3—nephrolithiasis	0.000298	0.000307	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—PTH—nephrolithiasis	0.00028	0.000289	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—CHRM3—nephrolithiasis	0.000249	0.000257	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—PTH—nephrolithiasis	0.000228	0.000235	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—AQP1—nephrolithiasis	0.000215	0.000221	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—CHRM3—nephrolithiasis	0.000194	0.0002	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—SPP1—nephrolithiasis	0.000151	0.000155	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—SPP1—nephrolithiasis	0.000141	0.000145	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—SPP1—nephrolithiasis	0.000114	0.000118	CbGpPWpGaD
